300110 华仁药业
已收盘 03-20 15:00:00
资讯
新帖
简况
国药药材品牌授权乱象
中国经营网 · 03-21 04:10
国药药材品牌授权乱象
华仁药业:二级市场股价波动受多方面因素影响
证券之星 · 03-17
华仁药业:二级市场股价波动受多方面因素影响
股市必读:华仁药业(300110)3月13日董秘有最新回复
证券之星 · 03-16
股市必读:华仁药业(300110)3月13日董秘有最新回复
华仁药业:截至2026年3月10日,公司股东总户数约为3.84万户
证券之星 · 03-13
华仁药业:截至2026年3月10日,公司股东总户数约为3.84万户
华仁药业:出口产品主要为基础输液、血液滤过置换基础液、腹膜透析液配件及医用包材等
证券之星 · 03-11
华仁药业:出口产品主要为基础输液、血液滤过置换基础液、腹膜透析液配件及医用包材等
华仁药业(300110)披露持股5%以上股东持股比例变动至5%以下暨权益变动的提示性公告,3月4日股价下跌0.95%
证券之星 · 03-04
华仁药业(300110)披露持股5%以上股东持股比例变动至5%以下暨权益变动的提示性公告,3月4日股价下跌0.95%
华仁药业:截至2026年2月27日,公司股东总户数约为3.92万户
证券之星 · 03-03
华仁药业:截至2026年2月27日,公司股东总户数约为3.92万户
华仁药业(300110)2月13日股东户数3.91万户,较上期减少0.51%
证券之星 · 03-02
华仁药业(300110)2月13日股东户数3.91万户,较上期减少0.51%
股市必读:华仁药业(300110)股东户数3.93万户,较上期增加1.03%
证券之星 · 02-24
股市必读:华仁药业(300110)股东户数3.93万户,较上期增加1.03%
华仁药业:截至2026年2月10日,公司股东总户数约为3.93万户
证券之星 · 02-13
华仁药业:截至2026年2月10日,公司股东总户数约为3.93万户
华仁药业:截至2026年2月10日,公司股东总户数约为3.93万户
证券之星 · 02-13
华仁药业:截至2026年2月10日,公司股东总户数约为3.93万户
华仁药业:截至2026年1月30日,公司股东总户数约为3.89万户
证券之星 · 02-04
华仁药业:截至2026年1月30日,公司股东总户数约为3.89万户
股市必读:华仁药业(300110)预计2025年全年归属净利润亏损3.6亿元至4.8亿元
证券之星 · 02-02
股市必读:华仁药业(300110)预计2025年全年归属净利润亏损3.6亿元至4.8亿元
华仁药业:预计2025年全年归属净利润亏损3.6亿元至4.8亿元
证券之星 · 01-30
华仁药业:预计2025年全年归属净利润亏损3.6亿元至4.8亿元
华仁药业:公司暂无相关规划
证券之星 · 01-27
华仁药业:公司暂无相关规划
股市必读:华仁药业(300110)股东户数3.92万户,较上期减少1.51%
证券之星 · 01-26
股市必读:华仁药业(300110)股东户数3.92万户,较上期减少1.51%
华仁药业(300110)1月20日股东户数3.92万户,较上期减少1.51%
证券之星 · 01-23
华仁药业(300110)1月20日股东户数3.92万户,较上期减少1.51%
华仁药业:截至2026年1月9日股东户数约3.98万户
证券之星 · 01-14
华仁药业:截至2026年1月9日股东户数约3.98万户
股市必读:1月9日华仁药业现1笔折价10.09%的大宗交易 合计成交88.2万元
证券之星 · 01-12
股市必读:1月9日华仁药业现1笔折价10.09%的大宗交易 合计成交88.2万元
股市必读:12月31日华仁药业现3笔大宗交易 机构净买入368.26万元
证券之星 · 01-05
股市必读:12月31日华仁药业现3笔大宗交易 机构净买入368.26万元
加载更多
公司概况
公司名称:
华仁药业股份有限公司
所属行业:
医药制造业
上市日期:
2010-08-25
主营业务:
华仁药业股份有限公司的主营业务是医药、医疗器械、医用包材、大健康、医药商业流通。公司的主要产品是基础输液、治疗制剂、腹透液、医疗器械、其他。公司是山东省应急储备定点输液生产企业,先后获得“全国AAA级信用企业”“国家知识产权优势/示范企业”“中国化学制药行业工业企业综合实力百强”“中国医药工业百强”“山东省质量管理奖”“山东省高端品牌培育企业”“‘品质鲁药’建设示范企业”等系列荣誉。
发行价格:
13.99
{"stockData":{"symbol":"300110","market":"SZ","secType":"STK","nameCN":"华仁药业","latestPrice":3.07,"timestamp":1773990198000,"preClose":3.18,"halted":0,"volume":30000344,"delay":0,"changeRate":-0.0346,"floatShares":1181000000,"shares":1182000000,"eps":-1.1922,"marketStatus":"已收盘","change":-0.11,"latestTime":"03-20 15:00:00","open":3.19,"high":3.22,"low":3.06,"amount":93474500,"amplitude":0.0503,"askPrice":3.08,"askSize":755,"bidPrice":3.07,"bidSize":337,"shortable":0,"etf":0,"ttmEps":-1.1922,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":5,"adr":0,"adjPreClose":3.18,"symbolType":"stock","openAndCloseTimeList":[[1773970200000,1773977400000],[1773982800000,1773990000000]],"highLimit":3.5,"lowLimit":2.86,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1182212982,"isCdr":false,"pbRate":2.77,"roa":"--","roe":"4.11%","epsLYR":-1.1576,"committee":0.192966,"marketValue":3629000000,"turnoverRate":0.0254,"status":1,"floatMarketCap":3625000000},"requestUrl":"/m/hq/s/300110","defaultTab":"news","newsList":[{"id":"2621757877","title":"国药药材品牌授权乱象","url":"https://stock-news.laohu8.com/highlight/detail?id=2621757877","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621757877?lang=zh_cn&edition=full","pubTime":"2026-03-21 04:10","pubTimestamp":1774037429,"startTime":"0","endTime":"0","summary":"“央企品质特供”“中国新中式滋补行业第一央企”“世界500强第80位”……近日,《中国经营报》记者注意到,在多个电商平台,有许多标注“国药药材”品牌的中药保健品、饮片在大量销售,这些商品甚至直接使用国药集团权威背景信息。国药药材全称为国药药材股份有限公司,曾因拖欠上市公司华仁药业(300110.SZ)14亿元以及多次被国药集团打假而在业内“闻名”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603213679341730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1515","00570","300110","BK0102","BK0239","BK1606"],"gpt_icon":0},{"id":"2620275844","title":"华仁药业:二级市场股价波动受多方面因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2620275844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620275844?lang=zh_cn&edition=full","pubTime":"2026-03-17 20:53","pubTimestamp":1773751981,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)03月17日在投资者关系平台上答复投资者关心的问题。投资者提问:腹膜透析作为国内前列的治疗药物!为什么股价在市场上表现的默默无闻!华仁药业回复:尊敬的投资者您好,二级市场股价波动受多方面因素影响。公司管理层始终以公司长远发展和股东利益为重,未来将继续努力提升公司经营质量,加速实施提升盈利能力的各项举措,努力提升上市公司投资价值,增强投资者回报水平。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700039744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2619048807","title":"股市必读:华仁药业(300110)3月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2619048807","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619048807?lang=zh_cn&edition=full","pubTime":"2026-03-16 03:30","pubTimestamp":1773603034,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,华仁药业报收于3.31元,上涨1.22%,换手率2.29%,成交量27.01万手,成交额8943.84万元。董秘最新回复投资者: 董秘你好!董秘: 尊敬的投资者您好,截至2026年3月10日,公司股东总户数约为3.84万户。当日关注点来自交易信息汇总:3月13日主力资金净流入78.85万元,游资资金同步净流入,显示市场资金对标的有一定关注度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600001336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2619197409","title":"华仁药业:截至2026年3月10日,公司股东总户数约为3.84万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2619197409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619197409?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:53","pubTimestamp":1773406406,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)03月13日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好!请问一下截止到2026.03.10的股东数是多少?谢谢!!!华仁药业回复:尊敬的投资者您好,截至2026年3月10日,公司股东总户数约为3.84万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300038536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"2618474059","title":"华仁药业:出口产品主要为基础输液、血液滤过置换基础液、腹膜透析液配件及医用包材等","url":"https://stock-news.laohu8.com/highlight/detail?id=2618474059","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618474059?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:52","pubTimestamp":1773233538,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)03月10日在投资者关系平台上答复投资者关心的问题。投资者提问:请问华仁在海外是否有医药业务?华仁药业回复:尊敬的投资者您好,公司出口产品主要为基础输液、血液滤过置换基础液、腹膜透析液配件及医用包材等,凭借先进的生产技术和严格的质量管控体系,已成功打开欧洲、亚洲、非洲及中东等多个国家的药品或包材市场。目前公司出口业务占比较小,公司将积极拓展国际业务,充分挖掘新的业绩增长点。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100037422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2616556713","title":"华仁药业(300110)披露持股5%以上股东持股比例变动至5%以下暨权益变动的提示性公告,3月4日股价下跌0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616556713","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616556713?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:27","pubTimestamp":1772634438,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘,华仁药业报收于3.12元,较前一交易日下跌0.95%,最新总市值为36.89亿元。华仁药业于近日披露《关于持股5%以上股东持股比例变动至5%以下暨权益变动的提示性公告》。自2019年12月19日至2026年3月3日,华仁世纪集团通过集中竞价及大宗交易方式累计减持公司股份,持股比例由11.34%降至4.84%。梁福东先生持股未变动。本次权益变动后,华仁世纪集团及其一致行动人合计持有公司股份59,110,605股,占总股本比例为4.999996%,不再为持股5%以上股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400040302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2616340575","title":"华仁药业:截至2026年2月27日,公司股东总户数约为3.92万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2616340575","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616340575?lang=zh_cn&edition=full","pubTime":"2026-03-03 20:51","pubTimestamp":1772542272,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2月底的股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年2月27日,公司股东总户数约为3.92万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300041978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2616938715","title":"华仁药业(300110)2月13日股东户数3.91万户,较上期减少0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616938715","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616938715?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:32","pubTimestamp":1772443927,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华仁药业披露,截至2026年2月13日公司股东户数为3.91万户,较2月10日减少200.0户,减幅为0.51%。在化学制药行业个股中,华仁药业股东户数高于行业平均水平,截至2月13日,化学制药行业平均股东户数为3.42万户。从股价来看,2026年2月10日至2026年2月13日,华仁药业区间跌幅为4.48%,在此期间股东户数减少200.0户,减幅为0.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200025661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2613318197","title":"股市必读:华仁药业(300110)股东户数3.93万户,较上期增加1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613318197","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613318197?lang=zh_cn&edition=full","pubTime":"2026-02-24 02:16","pubTimestamp":1771870572,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘,华仁药业报收于3.2元,下跌0.62%,换手率1.51%,成交量17.84万手,成交额5750.99万元。股本股东变化股东户数变动近日华仁药业披露,截至2026年2月10日公司股东户数为3.93万户,较1月30日增加400.0户,增幅为1.03%。户均持股数量由上期的3.04万股减少至3.01万股,户均持股市值为10.08万元。董秘: 尊敬的投资者您好,截至2026年2月10日,公司股东总户数约为3.93万户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400007483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2611866311","title":"华仁药业:截至2026年2月10日,公司股东总户数约为3.93万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2611866311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611866311?lang=zh_cn&edition=full","pubTime":"2026-02-13 11:48","pubTimestamp":1770954486,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)02月12日在投资者关系平台上答复投资者关心的问题。投资者提问:你好董秘,请问2026年2月10日股东人数有多少?华仁药业回复:尊敬的投资者您好,截至2026年2月10日,公司股东总户数约为3.93万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021300015668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2611518663","title":"华仁药业:截至2026年2月10日,公司股东总户数约为3.93万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2611518663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611518663?lang=zh_cn&edition=full","pubTime":"2026-02-13 11:48","pubTimestamp":1770954486,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)02月12日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 新年好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年2月10日A股股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年2月10日,公司股东总户数约为3.93万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021300015667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"2608614473","title":"华仁药业:截至2026年1月30日,公司股东总户数约为3.89万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608614473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608614473?lang=zh_cn&edition=full","pubTime":"2026-02-04 20:51","pubTimestamp":1770209499,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 新年好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年1月30日A股股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年1月30日,公司股东总户数约为3.89万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400039424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"gpt_icon":0},{"id":"2608018881","title":"股市必读:华仁药业(300110)预计2025年全年归属净利润亏损3.6亿元至4.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608018881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608018881?lang=zh_cn&edition=full","pubTime":"2026-02-02 05:08","pubTimestamp":1769980097,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,华仁药业报收于3.32元,下跌0.6%,换手率1.96%,成交量23.1万手,成交额7667.13万元。来自:华仁药业发布2025年度业绩预告,预计归母净利润亏损3.6亿元至4.8亿元,主要因商誉减值及产品售价下降所致,剔除商誉减值因素后预计实现净利润6,000万元至8,000万元。业绩披露要点业绩预告华仁药业发布业绩预告,预计2025年全年归属净利润亏损3.6亿元至4.8亿元。本次业绩预告未经注册会计师审计。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110"],"gpt_icon":0},{"id":"2607019690","title":"华仁药业:预计2025年全年归属净利润亏损3.6亿元至4.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607019690","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607019690?lang=zh_cn&edition=full","pubTime":"2026-01-30 18:19","pubTimestamp":1769768378,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业发布业绩预告,预计2025年全年归属净利润亏损3.6亿元至4.8亿元。剔除前述商誉减值因素影响后,公司预计 2025 年度实现归属于上市公司股东的净利润 6,000 万元-8,000 万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000034255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110"],"gpt_icon":0},{"id":"2606623784","title":"华仁药业:公司暂无相关规划","url":"https://stock-news.laohu8.com/highlight/detail?id=2606623784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606623784?lang=zh_cn&edition=full","pubTime":"2026-01-27 20:51","pubTimestamp":1769518291,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问:公司是否有意愿向新兴行业AI科技类行业靠拢,看看你们老的一套墨守成规的全输液输水带能在市场立足吗?华仁药业回复:尊敬的投资者,您好!公司暂无相关规划。公司密切关注行业动态和技术变革,致力于通过技术创新推动医药产业升级。公司将聚焦医药主业、深耕行业,加快推进医药制造现代化、智能化、产业化,实现高质量发展,努力为股东提供持续、稳定、合理的投资回报。感谢您的关注和建议!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700039531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2606265446","title":"股市必读:华仁药业(300110)股东户数3.92万户,较上期减少1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606265446","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606265446?lang=zh_cn&edition=full","pubTime":"2026-01-26 03:25","pubTimestamp":1769369114,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,华仁药业报收于3.38元,上涨1.5%,换手率2.19%,成交量25.88万手,成交额8685.9万元。当日关注点来自交易信息汇总:1月23日主力资金净流入186.78万元,显示主力对个股短期态度偏积极。股本股东变化股东户数变动近日华仁药业披露,截至2026年1月20日公司股东户数为3.92万户,较1月9日减少600.0户,减幅为1.51%。户均持股数量由上期的2.97万股增加至3.02万股,户均持股市值为9.83万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"2605475945","title":"华仁药业(300110)1月20日股东户数3.92万户,较上期减少1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605475945","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605475945?lang=zh_cn&edition=full","pubTime":"2026-01-23 17:41","pubTimestamp":1769161306,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华仁药业披露,截至2026年1月20日公司股东户数为3.92万户,较1月9日减少600.0户,减幅为1.51%。在化学制药行业个股中,华仁药业股东户数高于行业平均水平,截至1月20日,化学制药行业平均股东户数为3.43万户。从股价来看,2026年1月9日至2026年1月20日,华仁药业区间跌幅为0.31%,在此期间股东户数减少600.0户,减幅为1.51%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300029419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2603734615","title":"华仁药业:截至2026年1月9日股东户数约3.98万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2603734615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603734615?lang=zh_cn&edition=full","pubTime":"2026-01-14 20:52","pubTimestamp":1768395144,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问:新尊敬的董秘 年好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年1月9日A股股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年1月9日,公司股东总户数约为3.98万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400039152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"gpt_icon":0},{"id":"2602557136","title":"股市必读:1月9日华仁药业现1笔折价10.09%的大宗交易 合计成交88.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602557136","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602557136?lang=zh_cn&edition=full","pubTime":"2026-01-12 02:33","pubTimestamp":1768156388,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,华仁药业报收于3.27元,上涨0.62%,换手率1.9%,成交量22.49万手,成交额7303.48万元。当日关注点来自交易信息汇总:1月9日主力资金净流入674.14万元,显示主力对华仁药业股票的积极介入。来自交易信息汇总:当日发生一笔折价10.09%的大宗交易,合计成交88.2万元,反映部分股东减持意愿。大宗交易1月9日华仁药业现1笔折价10.09%的大宗交易,合计成交88.2万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200001016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2601024251","title":"股市必读:12月31日华仁药业现3笔大宗交易 机构净买入368.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601024251","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601024251?lang=zh_cn&edition=full","pubTime":"2026-01-05 04:55","pubTimestamp":1767560108,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,华仁药业报收于3.15元,上涨0.32%,换手率1.3%,成交量15.39万手,成交额4829.61万元。当日关注点来自交易信息汇总:12月31日主力资金净流出368.65万元,占总成交额7.63%。大宗交易12月31日华仁药业发生3笔大宗交易,机构净买入368.26万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500001595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774183680743,"stockEarnings":[{"period":"1week","weight":-0.0725},{"period":"1month","weight":-0.0406},{"period":"3month","weight":-0.0753},{"period":"6month","weight":-0.0781},{"period":"1year","weight":-0.0525},{"period":"ytd","weight":-0.0254}],"compareEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.0171},{"period":"6month","weight":0.0359},{"period":"1year","weight":0.1608},{"period":"ytd","weight":-0.003}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华仁药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38400人(较上一季度减少2.04%)","perCapita":"30751股","listingDate":"2010-08-25","address":"山东省青岛市崂山区高科技工业园株洲路187号","registeredCapital":"118221万元","survey":" 华仁药业股份有限公司的主营业务是医药、医疗器械、医用包材、大健康、医药商业流通。公司的主要产品是基础输液、治疗制剂、腹透液、医疗器械、其他。公司是山东省应急储备定点输液生产企业,先后获得“全国AAA级信用企业”“国家知识产权优势/示范企业”“中国化学制药行业工业企业综合实力百强”“中国医药工业百强”“山东省质量管理奖”“山东省高端品牌培育企业”“‘品质鲁药’建设示范企业”等系列荣誉。","listedPrice":13.99},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华仁药业,300110,华仁药业股票,华仁药业股票老虎,华仁药业股票老虎国际,华仁药业行情,华仁药业股票行情,华仁药业股价,华仁药业股市,华仁药业股票价格,华仁药业股票交易,华仁药业股票购买,华仁药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}